Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Stapleton

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
European Journal of Human Genetics : EJHG|January 24, 2022
Prevalence and natural history of schwannomas in neurofibromatosis type 2 (NF2): the influence of pathogenic variantsDaniel Moualed, Jonathan Wong, Owen Thomas, et al.
Journal of Neurological Surgery. Part B, Skull Base|February 14, 2022
Beyond Antoni: A Surgeon's Guide to the Vestibular Schwannoma MicroenvironmentCathal J Hannan, Daniel Lewis, Claire O'Leary, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|February 25, 2022
Cochlear Implantation in Neurofibromatosis Type 2: Experience From the UK Neurofibromatosis Type 2 ServiceMatthew E Smith, Rachel Edmiston, Mathieu Trudel, et al.
Journal of Medical Genetics|June 25, 2020
Sporadic vestibular schwannoma: a molecular testing summaryKatherine V Sadler, Naomi L Bowers, Claire Hartley, et al.
Neuro-Oncology|December 18, 2020
Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institutionClaire Forde, Andrew T King, Scott A Rutherford, et al.
Neuro-Oncology|November 3, 2018
Inflammation and vascular permeability correlate with growth in sporadic vestibular schwannomaDaniel Lewis, Federico Roncaroli, Erjon Agushi, et al.
Journal of Neurosurgery|May 30, 2020
The microenvironment in sporadic and neurofibromatosis type II-related vestibular schwannoma: the same tumor or different? A comparative imaging and neuropathology studyDaniel Lewis, Carmine A Donofrio, Claire O'Leary, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 8, 2018
Identifying the deficiencies of current diagnostic criteria for neurofibromatosis 2 using databases of 2777 individuals with molecular testingD Gareth Evans, Andrew T King, Naomi L Bowers, et al.
The Journal of Laryngology and Otology|April 22, 2024
Diagnostic criteria and core outcome set development for necrotising otitis externa: the COSNOE Delphi consensus studySirat Lodhi, Kirsty Dodgson, Michael Dykes, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 6, 2019
Incidence of mosaicism in 1055 de novo NF2 cases: much higher than previous estimates with high utility of next-generation sequencingD Gareth Evans, Claire L Hartley, Philip T Smith, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
European Journal of Human Genetics : EJHG|January 24, 2022
Prevalence and natural history of schwannomas in neurofibromatosis type 2 (NF2): the influence of pathogenic variantsDaniel Moualed, Jonathan Wong, Owen Thomas, et al.
Journal of Neurological Surgery. Part B, Skull Base|February 14, 2022
Beyond Antoni: A Surgeon's Guide to the Vestibular Schwannoma MicroenvironmentCathal J Hannan, Daniel Lewis, Claire O'Leary, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|February 25, 2022
Cochlear Implantation in Neurofibromatosis Type 2: Experience From the UK Neurofibromatosis Type 2 ServiceMatthew E Smith, Rachel Edmiston, Mathieu Trudel, et al.
Journal of Medical Genetics|June 25, 2020
Sporadic vestibular schwannoma: a molecular testing summaryKatherine V Sadler, Naomi L Bowers, Claire Hartley, et al.
Neuro-Oncology|December 18, 2020
Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institutionClaire Forde, Andrew T King, Scott A Rutherford, et al.
Neuro-Oncology|November 3, 2018
Inflammation and vascular permeability correlate with growth in sporadic vestibular schwannomaDaniel Lewis, Federico Roncaroli, Erjon Agushi, et al.
Journal of Neurosurgery|May 30, 2020
The microenvironment in sporadic and neurofibromatosis type II-related vestibular schwannoma: the same tumor or different? A comparative imaging and neuropathology studyDaniel Lewis, Carmine A Donofrio, Claire O'Leary, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 8, 2018
Identifying the deficiencies of current diagnostic criteria for neurofibromatosis 2 using databases of 2777 individuals with molecular testingD Gareth Evans, Andrew T King, Naomi L Bowers, et al.
The Journal of Laryngology and Otology|April 22, 2024
Diagnostic criteria and core outcome set development for necrotising otitis externa: the COSNOE Delphi consensus studySirat Lodhi, Kirsty Dodgson, Michael Dykes, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 6, 2019
Incidence of mosaicism in 1055 de novo NF2 cases: much higher than previous estimates with high utility of next-generation sequencingD Gareth Evans, Claire L Hartley, Philip T Smith, et al.
Pageof 5